[1] Weber KT, Brilla CG .Pathologic hypertrophy and cardiac interstitum. Fibrosis and reninangiotensin-aldosterone sys-tem[J] .Circulation, 1991, 83(6):1849-1865. [2] Harada K, Komuro I, Shioima I, et al.pressure overload induces cardiac hypertrophy in angiotensin Ⅱ type 1 (AT1) receptor knockoutmice[J] .Circulation, 1998, 97(19): 1952-1959. [3] 石杰, 胡有志, 屈松柏, 等.血压平逆转 2K1C 肾性高血压大鼠左室重构的作用及其机理的研究[J] .中国临床药理学与治疗学, 2005, 10(9):1053-1058. [4] 白玉鹏, 刘昌慧, 杨柳, 等.伊贝沙坦对结缔组织生长因子在自发性高血压大鼠心室肌表达的影响[J] .中国临床药理学与治疗学, 2005, 10(9):947-952. [5] Lopez B, Conzalez, Varo N, et al.Biochemical assess-ment of myocardial fibrosis in hertensive heart disease[J] . Hypertension, 2001, 38(5):1222-1226. [6] Swynghedauw B.Molecular Mechanisms of myocardial re-modeling[J] Physiological Rev, 1999, 79(1):219-262. [7] BryanWiliams. Angiotensin Ⅱ and the pathophysiology of cardiovascular remodeling[J] .Am J Cardiol, 2001, 87(8A):10C-17C. [8] Shokei Kim, Minoru Yoshiyama, Yasukatsu Izumi, et al.Effects of combination of ACE inhibitor and angiotensin re-ceptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure[J] .Circulation, 2001, 103(1):148-154. [9] Anderson B, Stromblad SO, Lomsky M, et al.Heart rate dependency of cardiac performance in heart failure patients treatedwith metoprolol[J] .Eur Heart J, 1999, 20(8): 575-583. [10] Lenfant C, Chobanian AV, Jones DW, et al.The Seventh Report of the Joint NationalCommittee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7):resetting the hypertension sails[J] .Hyperten-sion, 2003, 41(6):1178-1179 |